1887

Journal of General Virology header logo

Volume 89, Issue 2

Evaluation of drugs for treatment of prion infections of the central nervous system Free

Abstract

Prion diseases are fatal and at present there are neither cures nor therapies available to delay disease onset or progression in humans. Inspired in part by therapeutic approaches in the fields of Alzheimer's disease and amyotrophic lateral sclerosis, we tested five different drugs, which are known to efficiently pass through the blood–brain barrier, in a murine prion model. Groups of intracerebrally prion-challenged mice were treated with the drugs curcumin, dapsone, ibuprofen, memantine and minocycline. Treatment with antibiotics dapsone and minocycline had no therapeutic benefit. Ibuprofen-treated mice showed severe adverse effects, which prevented assessment of therapeutic efficacy. Mice treated with low- but not high-dose curcumin and mice treated with memantine survived infections significantly longer than untreated controls (<0.01). These results encourage further research efforts to improve the therapeutic effect of these drugs.

  • Received:
  • Accepted:
  • Published Online:
SGM
Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.83281-0
2008-02-01
2024-04-18
Loading full text...

Full text loading...

/deliver/fulltext/jgv/89/2/594.html?itemId=/content/journal/jgv/10.1099/vir.0.83281-0&mimeType=html&fmt=ahah

References

  1. Boshuizen R. S., Langeveld J. P., Salmona M., Williams A., Meloen R. H., Langedijk J. P. 2004; An in vitro screening assay based on synthetic prion protein peptides for identification of fibril-interfering compounds. Anal Biochem 333:372–380 [CrossRef]
     [Google Scholar]
  2. Burwinkel M., Riemer C., Schwarz A., Schultz J., Neidhold S., Bamme T., Baier M. 2004; Role of cytokines and chemokines in prion infections of the central nervous system. Int J Dev Neurosci 22:497–505 [CrossRef]
     [Google Scholar]
  3. Caughey B., Baron G. S. 2006; Prions and their partners in crime. Nature 443:803–810 [CrossRef]
     [Google Scholar]
  4. Caughey B., Raymond L. D., Raymond G. J., Maxson L., Silveira J., Baron G. S. 2003; Inhibition of protease-resistant prion protein accumulation in vitro by curcumin. J Virol 77:5499–5502 [CrossRef]
     [Google Scholar]
  5. Forloni G., Iussich S., Awan T., Colombo L., Angeretti N., Girola L., Bertani I., Poli G., Caramelli M. other authors 2002; Tetracyclines affect prion infectivity. Proc Natl Acad Sci U S A 99:10849–10854 [CrossRef]
     [Google Scholar]
  6. Garcia-Alloza M., Borrelli L. A., Rozkalne A., Hyman B. T., Bacskai B. J. 2007; Curcumin labels amyloid pathology in vivo , disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J Neurochem 102:1095–1104 [CrossRef]
     [Google Scholar]
  7. Gautam S. C., Gao X., Dulchavsky S. 2007; Immunomodulation by curcumin. Adv Exp Med Biol 595:321–341
     [Google Scholar]
  8. Guenther K., Deacon R. M., Perry V. H., Rawlins J. N. 2001; Early behavioural changes in scrapie-affected mice and the influence of dapsone. Eur J Neurosci 14:401–409 [CrossRef]
     [Google Scholar]
  9. Jin K., Xie L., Mao X. O., Greenberg D. A. 2006; Alzheimer's disease drugs promote neurogenesis. Brain Res 1085:183–188 [CrossRef]
     [Google Scholar]
  10. Jonas M., Cunha B. A. 1982; Minocycline. Ther Drug Monit 4:137–145
     [Google Scholar]
  11. Kempster S., Bate C., Williams A. 2007; Simvastatin treatment prolongs the survival of scrapie-infected mice. Neuroreport 18:479–482 [CrossRef]
     [Google Scholar]
  12. Kocisko D. A., Morrey J. D., Race R. E., Chen J., Caughey B. 2004; Evaluation of new cell culture inhibitors of protease-resistant prion protein against scrapie infection in mice. J Gen Virol 85:2479–2483 [CrossRef]
     [Google Scholar]
  13. Kriz J., Nguyen M. D., Julien J. P. 2002; Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 10:268–278 [CrossRef]
     [Google Scholar]
  14. Larramendy-Gozalo C., Barret A., Daudigeos E., Mathieu E., Antonangeli L., Riffet C., Petit E., Papy-Garcia D., Barritault D. other authors 2007; Comparison of CR36, a new heparan mimetic, and pentosan polysulfate in the treatment of prion diseases. J Gen Virol 88:1062–1067 [CrossRef]
     [Google Scholar]
  15. Lim G. P., Yang F., Chu T., Chen P., Beech W., Teter B., Tran T., Ubeda O., Hsiao-Ashe K. other authors 2000; Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J Neurosci 20:5709–5714
     [Google Scholar]
  16. Lim G. P., Chu T., Yang F., Beech W., Frautschy S. A., Cole G. M. 2001; The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 21:8370–8377
     [Google Scholar]
  17. Manuelidis L., Fritch W., Zaitsev I. 1998; Dapsone to delay symptoms in Creutzfeldt-Jakob disease. Lancet 352:456 [CrossRef]
     [Google Scholar]
  18. Menon V. P., Sudheer A. R. 2007; Antioxidant and anti-inflammatory properties of curcumin. Adv Exp Med Biol 595:105–125
     [Google Scholar]
  19. Mok S. W., Thelen K. M., Riemer C., Bamme T., Gultner S., Lutjohann D., Baier M. 2006; Simvastatin prolongs survival times in prion infections of the central nervous system. Biochem Biophys Res Commun 348:697–702 [CrossRef]
     [Google Scholar]
  20. Mok S. W., Riemer C., Madela K., Hsu D. K., Liu F. T., Gultner S., Heise I., Baier M. 2007; Role of galectin-3 in prion infections of the CNS. Biochem Biophys Res Commun 359:672–678 [CrossRef]
     [Google Scholar]
  21. Muller W. E., Ushijima H., Schroder H. C., Forrest J. M., Schatton W. F., Rytik P. G., Heffner-Lauc M. 1993; Cytoprotective effect of NMDA receptor antagonists on prion protein (PrionSc)-induced toxicity in rat cortical cell cultures. Eur J Pharmacol 246:261–267 [CrossRef]
     [Google Scholar]
  22. Prusiner S. B. 1998; Prions. Proc Natl Acad Sci U S A 95:13363–13383 [CrossRef]
     [Google Scholar]
  23. Reisberg B., Doody R., Stoffler A., Schmitt F., Ferris S., Mobius H. J. 2003; Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med 348:1333–1341 [CrossRef]
     [Google Scholar]
  24. Sassoon J., Daniels M., Brown D. R. 2004; Astrocytic regulation of NMDA receptor subunit composition modulates the toxicity of prion peptide PrP106–126. Mol Cell Neurosci 25:181–191 [CrossRef]
     [Google Scholar]
  25. Scallet A. C., Ye X. 1997; Excitotoxic mechanisms of neurodegeneration in transmissible spongiform encephalopathies. Ann N Y Acad Sci 825:194–205 [CrossRef]
     [Google Scholar]
  26. Schultz J., Schwarz A., Neidhold S., Burwinkel M., Riemer C., Simon D., Kopf M., Otto M., Baier M. 2004; Role of interleukin-1 in prion disease-associated astrocyte activation. Am J Pathol 165:671–678 [CrossRef]
     [Google Scholar]
  27. Trevitt C. R., Collinge J. 2006; A systematic review of prion therapeutics in experimental models. Brain 129:2241–2265 [CrossRef]
     [Google Scholar]
  28. Yang F., Lim G. P., Begum A. N., Ubeda O. J., Simmons M. R., Ambegaokar S. S., Chen P. P., Kayed R., Glabe C. G. other authors 2005; Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo . J Biol Chem 280:5892–5901 [CrossRef]
     [Google Scholar]
  29. Zhu S., Stavrovskaya I. G., Drozda M., Kim B. Y., Ona V., Li M., Sarang S., Liu A. S., Hartley D. M. other authors 2002; Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 417:74–78 [CrossRef]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.83281-0
Loading
Evaluation of drugs for treatment of prion infections of the central nervous system
J. Gen. Virol. 89, 594 (2008); https://doi.org/10.1099/vir.0.83281-0
/content/journal/jgv/10.1099/vir.0.83281-0
/content/journal/jgv/10.1099/vir.0.83281-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error